title: [Ependymoma of ovary: report of a case].
authors.forename: Kai-xuan
authors.initials: KX
authors.lastname: Yang
authors.forename: Yu
authors.initials: Y
authors.lastname: Wan
authors.forename: Lian
authors.initials: L
authors.lastname: Xu
authors.forename: Liang
authors.initials: L
authors.lastname: Sun
authors.forename: Zheng-yu
authors.initials: ZY
authors.lastname: Li
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D018283:Cystadenocarcinoma, Papillary / Q000473:pathology; D003609:Dactinomycin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004806:Ependymoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006801:Humans; D007044:Hysterectomy; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D010052:Ovariectomy; D013724:Teratoma / Q000473:pathology; D014746:Vimentin / Q000378:metabolism; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D005904:Glial Fibrillary Acidic Protein; D014746:Vimentin; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide